BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1862957)

  • 1. [Acceleration of the restoration of conditioned reflexes following anesthesia using aminostigmine].
    Prozorovskiĭ VB; Iudkina NI
    Anesteziol Reanimatol; 1991; (1):25-6. PubMed ID: 1862957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New data on the pharmacokinetics of aminostigmine].
    Prozorovskiĭ VB; Chepur SV; Vorob'ev-Desiatovskiĭ NV; Panov PB
    Eksp Klin Farmakol; 1998; 61(5):46-9. PubMed ID: 9854634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The toxicological characteristics of the interaction of cholinolytics with aminostigmine--a new reversible cholinesterase inhibitor].
    Prozorovskiĭ VB; Sazonova AV
    Eksp Klin Farmakol; 1995; 58(5):57-61. PubMed ID: 8704593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aminostigmine as a cholinesterase inhibitor and as an agent for treating poisonings by cholinergic blockers].
    Prozorovskiĭ VB; Livanov GA; Velikova VD; Afanas'ev VV; Pavlova LV
    Eksp Klin Farmakol; 1994; 57(5):13-5. PubMed ID: 7696893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The pharmacological characteristics of the new anticholinesterase drug aminostigmine].
    Prozorovskiĭ VB; Pavlova LV; Suslova IM; Shchemeleva NI
    Eksp Klin Farmakol; 1992; 55(1):13-6. PubMed ID: 1305425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biochemical characteristics of aminostigmine--a new anticholinesterase agent].
    Prozorovskiĭ VB; Rozengart VI; Ardab'eva TV; Kugusheva LI; Suslova IM
    Biokhimiia; 1996 Apr; 61(4):690-6. PubMed ID: 8724787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The comparative clinico-experimental characteristics of aminostigmine and galanthamine used for treating poisonings by choline-blocking substances].
    Prozorovskiĭ VB; Velikova VD; Pshenkina NN; Vasilenko ET
    Eksp Klin Farmakol; 1996; 59(1):64-7. PubMed ID: 8704639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bizerine: new anticholinesterase drug with selective gastrointestinal action].
    Prozorovskiĭ VB; Pavlova LV; Suslova IM; Sazonova AV; Shchemeleva NI
    Eksp Klin Farmakol; 2010 Aug; 73(8):14-6. PubMed ID: 20919551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protection of mice by carbamates cholinesterase inhibitors against poisoning by armin and its dependence on certain physico-chemical indicators].
    Prozorovskiĭ VB; Pavlova LV; Suslova IM; Sazonova AV; Kokushkina AV
    Vopr Med Khim; 1999; 45(6):525-9. PubMed ID: 10761219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aminostigmine-a novel drug against home poisoning].
    Bonitenko II; Safronov GA; Sosiukin AE; Pershin VN; Shpilenia LS
    Klin Med (Mosk); 1996; 74(8):58-61. PubMed ID: 9036214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histamine blockers increase efficacy of specific antidote prophylaxis of intoxication by cholinesterase inhibitors in mice].
    Prozorovskiĭ VB; Skopichev VG; Ditiateva ZhA; Sazonova AV
    Eksp Klin Farmakol; 2000; 63(4):64-7. PubMed ID: 11022312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the role of the brain cholinergic system in the mechanisms of dissociative learning.
    Azarashvili AA
    Neurosci Behav Physiol; 1997; 27(4):341-6. PubMed ID: 9252989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of amiridine on the state of conditioned reflex in rats with injured hippocampus].
    Mering TA; Kuleshova EN; Viktorov IV; Burov IuV
    Biull Eksp Biol Med; 1997 Feb; 123(2):173-5. PubMed ID: 9280489
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ability of reversible cholinesterase inhibitors to support dissociative learning].
    Azarashvili AA; Arkhipov VI; Budantsev AIu; Prozorovskiĭ VB
    Farmakol Toksikol; 1987; 50(3):27-9. PubMed ID: 3609271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the question of change of activity of cholinesterase and of conditioned reflex of animals in methylnitrophos poisoning].
    Shigan SA; Korolev AA
    Farmakol Toksikol; 1968; 31(5):556-9. PubMed ID: 5707724
    [No Abstract]   [Full Text] [Related]  

  • 16. Possibility of usage of aminostigmine structural analogue for the treatment of toxic cognitive disorders.
    Fateev IV; Subbotina SN; Kurpyakova AF; Tyunin MA
    Bull Exp Biol Med; 2014 Jan; 156(3):353-6. PubMed ID: 24771374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xylazine-ketamine-induced anesthesia in rats and its antagonism by yohimbine.
    Hsu WH; Bellin SI; Dellmann HD; Hanson CE
    J Am Vet Med Assoc; 1986 Nov; 189(9):1040-3. PubMed ID: 3505923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated stress in combination with pyridostigmine Part I: long-term behavioural consequences.
    Lamproglou I; Barbier L; Diserbo M; Fauvelle F; Fauquette W; Amourette C
    Behav Brain Res; 2009 Feb; 197(2):301-10. PubMed ID: 18793677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of 8-Br-cAMP on the formation of conditioned reflex behavior in the white rat].
    Danilova RA; Gurevich EV; Storozheva ZI
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(2):267-71. PubMed ID: 2992185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of aminostigmine on the parameters of nonspecific resistance and immune system of the organism upon acute poisoning of benzyl 3-quinuclidylate].
    Zabrodskiĭ PF; Troshkin NM; Germanchuk VG; Sidel'nikova NM; Lim VG
    Eksp Klin Farmakol; 2005; 68(6):40-2. PubMed ID: 16405033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.